慢性阻塞性肺疾病合并胃食管反流病的研究進展_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

樊建勇 ¹ ,  秦燕 ²

1. ;
2. ;

Corresponding?author：

秦燕, Email: 66900555@qq.com

Keywords：

DOI：

10.7507/1671-6205.201803036

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 樊建勇, 秦燕. 慢性阻塞性肺疾病合并胃食管反流病的研究進展. Chinese Journal of Respiratory and Critical Care Medicine, 2019, 18(3): 295-299. doi: 10.7507/1671-6205.201803036 Copy

1.	Tsai CL, Lin YH, Wang MT, et al. Gastro-oesophageal reflux disease increases the risk of intensive care unit admittance and mechanical ventilation use among patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study. Crit Care, 2015, 19: 110.
2.	Lee AL, Goldstein RS. Gastroesophageal reflux disease in COPD: links and risks. Int J Chron Obstruct Pulmon Dis, 2015, 10: 1935-1949.
3.	Timms C, Thomas PS, Yates DH. Detection of gastro-oesophageal reflux disease (CORD) in patients with obstructive lung disease using exhaled breath profiling. J Breath Res, 2012, 6(1): 016003.
4.	Martinez CH, Okajima Y, Murray S, et al. Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort. Respir Res, 2014, 15: 62.
5.	Kempainen RR, Savik K, Whelan TP, et al. High prevalence of proximal and distal gastroesophageal reflux disease in advanced COPD. Chest, 2007, 131(6): 1666-1671.
6.	Baumeler L, Papakonstantinou E, Mienkovic B, et al. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD. Respirology, 2016, 21(5): 883-890.
7.	Ajmera M, Raval AD, Shen C;, et al. Explaining the increased health care expenditures associated with gastroesophageal reflux disease among elderly Medicare beneficiaries with chronic obstructive pulmonary disease: a cost-decomposition analysis. Int J Chron Obstruct Pulmon Dis, 2014, 9(8): 339-348.
8.	Lacy BE, Chehade R, Crowell MD. A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11). Am J Gastroenterol, 2011, 106(9): 1604-1611.
9.	Sweet MP, Patti MG, Hoopes C, et al. Gastro-oesophageal reflux and aspiration in patients with advanced lung disease. Thorax, 2009, 64(2): 167-173.
10.	El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut, 2014, 63(6): 871-880.
11.	El-Serag HB, Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology, 1997, 113(3): 755-760.
12.	García Rodríguez LA, Ruigómez A, Martín-Merino E, et al. Relationship between gastroesophageal reflux disease and COPD in UK primary care. Chest, 2008, 134(6): 1223-1230.
13.	Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health[CPH] study): a national cross-sectional study. Lancet, 2018, 391(10131): 1706-1717.
14.	Kohata Y, Fujiwara Y, Watanabe T, et al. Long-term benefits of smoking cessation on gastroesophageal reflux disease and health-related quality of life. PLoS One, 2016, 11(2): e0147860.
15.	Kubo A, Levin TR, Block G, et al. Cigarette smoking and the risk of Barrett's esophagus. Cancer Causes Control, 2009, 20(3): 303-311.
16.	Martinucci I, de Bortoli N, Giacchino M, et al. Esophageal motility abnormalities in gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther, 2014, 5(2): 86-96.
17.	Kim YS, Kim N, Kim GH. Sex and gender differences in gastroesophageal reflux disease. J Neurogastroenterol Motil, 2016, 22(4): 575-588.
18.	Hallan A, Bomme M, Hveem K, et al. Risk factors on the development of new-onset gastroesophageal reflux symptoms. A population-based prospective cohort study: the HUNT study. Am J Gastroenterol, 2015, 110(3): 393-400.
19.	Liang BM, Feng YL. Association of gastroesophageal reflux disease symptoms with stable chronic obstructive pulmonary disease. Lung, 2012, 190: 277-282.
20.	Rogha M, Behravesh B, Pourmoghaddas Z. Association of gastroesophageal reflux disease symptoms with exacerbations of chronic obstructive pulmonary disease. J Gastrointestin Liver Dis, 2010, 19(3): 253-256.
21.	Liang B, Wang M, Yi Q, et al. Association of gastroesophageal reflux disease risk with exacerbations of chronic obstructive pulmonary disease. Dis Esophagus, 2013, 26(6): 557-560.
22.	Leggett CL, Gorospe EC, Calvin AD, et al. Obstructive sleep apnea is a risk factor for Barrett's esophagus. Clin Gastroenterol Hepatol, 2014, 12(4): 583-588.
23.	Hom C, Vaezi MF. Extra-esophageal manifestations of gastroesophageal reflux disease: diagnosis and treatment. Drug, 2013, 73(12): 1281-1295.
24.	Tack J, Pandolfino, J E. Pathophysiology of gastroesophageal reflux disease. Gastroenterology, 2018, 154(2): 277-288.
25.	Mitchell DR, Derakhshan MH, Wirz AA, et al. Abdominal compression by waist belt aggravates gastroesophageal reflux, primarily by impairing esophageal clearance. Gastroenterology, 2017, 152(8): 1881-1888.
26.	Gadel AA, Mostafa M, Younis A, et al. Esophageal motility pattern and gastro-esophageal reflux in chronic obstructive pulmonary disease. Hepatogastroenterology, 2012, 59(120): 2498-2502.
27.	Terada K, Muro S, Ohara T, et al. Abnormal swallowing reflex and COPD exacerbations. Chest, 2010, 137(2): 326-332.
28.	Ness-Jensen E, Lindam A, Lagergren J, et al. Tobacco smoking cessation and improved gastroesophageal reflux: a prospective population-based cohort study: the HUNT study. Am J Gastroenterol, 2014, 109(2): 171-177.
29.	朱廣昌, 汪忠鎬, 胡志偉, 等. 咽噴嘴與噴灑: 胃食管反流對氣道的侵襲. 中華實驗外科雜志, 2014, 31(2): 330-332.
30.	汪忠鎬, 高翔, 來運剛, 等. 咽噴嘴及3S現象: 胃食管氣道反流的實驗研究. 臨床誤診誤治, 2011, 24(3): 5-7.
31.	汪忠鎬, 胡志偉. 胃食管反流病及其食管外反流: 一個常被忽視的重大公共衛生問題. 臨床外科雜志, 2016, 24(1): 5-11.
32.	Pauwels A, Blondeau K, Dupont LJ, et al. Mechanisms of gastroesophageal reflux in patients with cystic fibrosis. Am J Gatroenterol, 2012, 107(9): 1346-1353.
33.	Ozkaya S, Dirican A, Kaya SO, et al. The relationship between early reversibility test and maximal inspiratory pressure in patients with airway obstruction. Int J Chron Obstruct Pulmon Dis, 2014, 9: 453-456.
34.	Kim SW, Lee JH, Sim YS, et al. Prevalence and risk factors for reflux esophagitis in patients with chronic obstructive pulmonary disease. Korean J Intern Med, 2014, 29(4): 466-473.
35.	Del Grande LM, Herbella FAM, Bigatao AM, et al. Inhaled beta agonist bronchodilator does not affect trans-diaphragmatic pressure gradient but decreases lower esophageal sphincter retention pressure in patients with chronic obstructive pulmonary disease (COPD) and gastroesophageal reflux disease (GERD). J Gastrointest Surg, 2016, 20(10): 1679-1682.
36.	Naliboff BD, Mayer M, Fass R, et al. The effect of life stress on symptoms of heartburn. Psychosom Med, 2004, 66(3): 426-434.
37.	胡志偉, 汪忠鎬, 吳繼敏, 等. 胃食管反流相關呼吸疾病及其外科治療策略. 臨床誤診誤治, 2013, 26(7): 62-66.
38.	Hunt R, Armstrong D, Katelaris P, et al. World Gastroenterology Organisation Global Guidelines: GERD Global Perspective on Gastroesophageal Reflux Disease. J Clin Gastroenterol, 2017, 51(6): 467-478.
39.	Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol, 2006, 101(11): 2619-2628.
40.	Lee AL, Button BM, Denehy L, et al. Proximal and distal gastro-oesophageal reflux in chronic obstructive pulmonary disease and brochiectasis. Respirology, 2014, 19(2): 211-217.
41.	Kwasnicki RM, Ley Greaves R, Ali R, et al. Implementation of objective activity monitoring to supplement the interpretation of ambulatory esophageal pH investigations. Dis Esophagus, 2016, 29(3): 255-261.
42.	Chrysos E, Athanasakis E, Zoras OJ, et al. Twenty-four-hour ambulatory versus stationary esophageal manometry in the evaluation of esophageal motility in patients with gastroesophageal reflux disease. Digestion, 2002, 66(1): 1-8.
43.	Van Hoeij FB, Weijenborg PW, Van den Bergh Weerman MA, et al. Mucosal integrity and sensitivity to acid in the proximal esophagus in patients with gastroesophageal reflux disease. Am J Physiol Gastrointest Liver Physiol, 2016, 311(1): G117-G122.
44.	Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut, 2018, 67(7): 1351-1362.
45.	Broers C, Tack J, Pauwels A. Review article: gastro-oesophageal reflux disease in asthma and chronic obstructive pulmonary disease. Aliment Pharmacol Ther, 2018, 47(2): 176-191.
46.	Sidhwa F, Moore A, Alligood E, et al. Diagnosis and treatment of the extraesophageal manifestations of gastroesophageal reflux disease. Ann Surg, 2017, 265(1): 63-67.
47.	Nagami S, Oku Y, Yagi N, et al. Breathing-swallowing discoordination is associated with frequent exacerbations of COPD. BMJ Open Respir Res, 2017, 4(1): e000202.
48.	Lee AL, Button BM, Denehy L, et al. Exhaled breath condensate pepsin: potential noninvasive test for gastrophageal reflux in COPD and bronchiectasis. Respir Care, 2015, 60(2): 244-250.
49.	Iliaz S, Iliaz R, Onur ST, et al. Does gastroesophageal reflux increase chronic obstructive pulmonary disease exacerbations?. Respir Med, 2016, 115: 20-25.
50.	Sakae TM, Pizzichini MM, Teixeira PJ, et al. Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis. J Bras Pneumol, 2013, 39(3): 259-271.
51.	Ingebrigtsen TS, Marott JL, Vestbo J, et al. Gastro-esophageal reflux disease and exacerbations in chronic obstructive pulmonary disease. Respirology, 2015, 20(1): 101-107.
52.	Mokhlesi B, Morris AL, Huang CF, et al. Increased prevalence of gastroesophageal reflux symptoms in patients with COPD. Chest, 2001, 119(4): 1043-1048.
53.	Benson VS, Mullerova H, Vestbo J, et al. Associations between gastro-esophageal reflux, its management and exacerbations of chronic obstructive pulmonary disease. Respir Med, 2015, 109(9): 1147-1154.
54.	李慧靈, 阿不來提.艾則孜, 張成, 等胃食管反流病診治進展. 中華胃食管反流病電子雜志, 2015, 2(3): 175-177.

1. Tsai CL, Lin YH, Wang MT, et al. Gastro-oesophageal reflux disease increases the risk of intensive care unit admittance and mechanical ventilation use among patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study. Crit Care, 2015, 19: 110.
2. Lee AL, Goldstein RS. Gastroesophageal reflux disease in COPD: links and risks. Int J Chron Obstruct Pulmon Dis, 2015, 10: 1935-1949.
3. Timms C, Thomas PS, Yates DH. Detection of gastro-oesophageal reflux disease (CORD) in patients with obstructive lung disease using exhaled breath profiling. J Breath Res, 2012, 6(1): 016003.
4. Martinez CH, Okajima Y, Murray S, et al. Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort. Respir Res, 2014, 15: 62.
5. Kempainen RR, Savik K, Whelan TP, et al. High prevalence of proximal and distal gastroesophageal reflux disease in advanced COPD. Chest, 2007, 131(6): 1666-1671.
6. Baumeler L, Papakonstantinou E, Mienkovic B, et al. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD. Respirology, 2016, 21(5): 883-890.
7. Ajmera M, Raval AD, Shen C;, et al. Explaining the increased health care expenditures associated with gastroesophageal reflux disease among elderly Medicare beneficiaries with chronic obstructive pulmonary disease: a cost-decomposition analysis. Int J Chron Obstruct Pulmon Dis, 2014, 9(8): 339-348.
8. Lacy BE, Chehade R, Crowell MD. A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11). Am J Gastroenterol, 2011, 106(9): 1604-1611.
9. Sweet MP, Patti MG, Hoopes C, et al. Gastro-oesophageal reflux and aspiration in patients with advanced lung disease. Thorax, 2009, 64(2): 167-173.
10. El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut, 2014, 63(6): 871-880.
11. El-Serag HB, Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology, 1997, 113(3): 755-760.
12. García Rodríguez LA, Ruigómez A, Martín-Merino E, et al. Relationship between gastroesophageal reflux disease and COPD in UK primary care. Chest, 2008, 134(6): 1223-1230.
13. Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health[CPH] study): a national cross-sectional study. Lancet, 2018, 391(10131): 1706-1717.
14. Kohata Y, Fujiwara Y, Watanabe T, et al. Long-term benefits of smoking cessation on gastroesophageal reflux disease and health-related quality of life. PLoS One, 2016, 11(2): e0147860.
15. Kubo A, Levin TR, Block G, et al. Cigarette smoking and the risk of Barrett's esophagus. Cancer Causes Control, 2009, 20(3): 303-311.
16. Martinucci I, de Bortoli N, Giacchino M, et al. Esophageal motility abnormalities in gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther, 2014, 5(2): 86-96.
17. Kim YS, Kim N, Kim GH. Sex and gender differences in gastroesophageal reflux disease. J Neurogastroenterol Motil, 2016, 22(4): 575-588.
18. Hallan A, Bomme M, Hveem K, et al. Risk factors on the development of new-onset gastroesophageal reflux symptoms. A population-based prospective cohort study: the HUNT study. Am J Gastroenterol, 2015, 110(3): 393-400.
19. Liang BM, Feng YL. Association of gastroesophageal reflux disease symptoms with stable chronic obstructive pulmonary disease. Lung, 2012, 190: 277-282.
20. Rogha M, Behravesh B, Pourmoghaddas Z. Association of gastroesophageal reflux disease symptoms with exacerbations of chronic obstructive pulmonary disease. J Gastrointestin Liver Dis, 2010, 19(3): 253-256.
21. Liang B, Wang M, Yi Q, et al. Association of gastroesophageal reflux disease risk with exacerbations of chronic obstructive pulmonary disease. Dis Esophagus, 2013, 26(6): 557-560.
22. Leggett CL, Gorospe EC, Calvin AD, et al. Obstructive sleep apnea is a risk factor for Barrett's esophagus. Clin Gastroenterol Hepatol, 2014, 12(4): 583-588.
23. Hom C, Vaezi MF. Extra-esophageal manifestations of gastroesophageal reflux disease: diagnosis and treatment. Drug, 2013, 73(12): 1281-1295.
24. Tack J, Pandolfino, J E. Pathophysiology of gastroesophageal reflux disease. Gastroenterology, 2018, 154(2): 277-288.
25. Mitchell DR, Derakhshan MH, Wirz AA, et al. Abdominal compression by waist belt aggravates gastroesophageal reflux, primarily by impairing esophageal clearance. Gastroenterology, 2017, 152(8): 1881-1888.
26. Gadel AA, Mostafa M, Younis A, et al. Esophageal motility pattern and gastro-esophageal reflux in chronic obstructive pulmonary disease. Hepatogastroenterology, 2012, 59(120): 2498-2502.
27. Terada K, Muro S, Ohara T, et al. Abnormal swallowing reflex and COPD exacerbations. Chest, 2010, 137(2): 326-332.
28. Ness-Jensen E, Lindam A, Lagergren J, et al. Tobacco smoking cessation and improved gastroesophageal reflux: a prospective population-based cohort study: the HUNT study. Am J Gastroenterol, 2014, 109(2): 171-177.
29. 朱廣昌, 汪忠鎬, 胡志偉, 等. 咽噴嘴與噴灑: 胃食管反流對氣道的侵襲. 中華實驗外科雜志, 2014, 31(2): 330-332.
30. 汪忠鎬, 高翔, 來運剛, 等. 咽噴嘴及3S現象: 胃食管氣道反流的實驗研究. 臨床誤診誤治, 2011, 24(3): 5-7.
31. 汪忠鎬, 胡志偉. 胃食管反流病及其食管外反流: 一個常被忽視的重大公共衛生問題. 臨床外科雜志, 2016, 24(1): 5-11.
32. Pauwels A, Blondeau K, Dupont LJ, et al. Mechanisms of gastroesophageal reflux in patients with cystic fibrosis. Am J Gatroenterol, 2012, 107(9): 1346-1353.
33. Ozkaya S, Dirican A, Kaya SO, et al. The relationship between early reversibility test and maximal inspiratory pressure in patients with airway obstruction. Int J Chron Obstruct Pulmon Dis, 2014, 9: 453-456.
34. Kim SW, Lee JH, Sim YS, et al. Prevalence and risk factors for reflux esophagitis in patients with chronic obstructive pulmonary disease. Korean J Intern Med, 2014, 29(4): 466-473.
35. Del Grande LM, Herbella FAM, Bigatao AM, et al. Inhaled beta agonist bronchodilator does not affect trans-diaphragmatic pressure gradient but decreases lower esophageal sphincter retention pressure in patients with chronic obstructive pulmonary disease (COPD) and gastroesophageal reflux disease (GERD). J Gastrointest Surg, 2016, 20(10): 1679-1682.
36. Naliboff BD, Mayer M, Fass R, et al. The effect of life stress on symptoms of heartburn. Psychosom Med, 2004, 66(3): 426-434.
37. 胡志偉, 汪忠鎬, 吳繼敏, 等. 胃食管反流相關呼吸疾病及其外科治療策略. 臨床誤診誤治, 2013, 26(7): 62-66.
38. Hunt R, Armstrong D, Katelaris P, et al. World Gastroenterology Organisation Global Guidelines: GERD Global Perspective on Gastroesophageal Reflux Disease. J Clin Gastroenterol, 2017, 51(6): 467-478.
39. Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol, 2006, 101(11): 2619-2628.
40. Lee AL, Button BM, Denehy L, et al. Proximal and distal gastro-oesophageal reflux in chronic obstructive pulmonary disease and brochiectasis. Respirology, 2014, 19(2): 211-217.
41. Kwasnicki RM, Ley Greaves R, Ali R, et al. Implementation of objective activity monitoring to supplement the interpretation of ambulatory esophageal pH investigations. Dis Esophagus, 2016, 29(3): 255-261.
42. Chrysos E, Athanasakis E, Zoras OJ, et al. Twenty-four-hour ambulatory versus stationary esophageal manometry in the evaluation of esophageal motility in patients with gastroesophageal reflux disease. Digestion, 2002, 66(1): 1-8.
43. Van Hoeij FB, Weijenborg PW, Van den Bergh Weerman MA, et al. Mucosal integrity and sensitivity to acid in the proximal esophagus in patients with gastroesophageal reflux disease. Am J Physiol Gastrointest Liver Physiol, 2016, 311(1): G117-G122.
44. Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut, 2018, 67(7): 1351-1362.
45. Broers C, Tack J, Pauwels A. Review article: gastro-oesophageal reflux disease in asthma and chronic obstructive pulmonary disease. Aliment Pharmacol Ther, 2018, 47(2): 176-191.
46. Sidhwa F, Moore A, Alligood E, et al. Diagnosis and treatment of the extraesophageal manifestations of gastroesophageal reflux disease. Ann Surg, 2017, 265(1): 63-67.
47. Nagami S, Oku Y, Yagi N, et al. Breathing-swallowing discoordination is associated with frequent exacerbations of COPD. BMJ Open Respir Res, 2017, 4(1): e000202.
48. Lee AL, Button BM, Denehy L, et al. Exhaled breath condensate pepsin: potential noninvasive test for gastrophageal reflux in COPD and bronchiectasis. Respir Care, 2015, 60(2): 244-250.
49. Iliaz S, Iliaz R, Onur ST, et al. Does gastroesophageal reflux increase chronic obstructive pulmonary disease exacerbations?. Respir Med, 2016, 115: 20-25.
50. Sakae TM, Pizzichini MM, Teixeira PJ, et al. Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis. J Bras Pneumol, 2013, 39(3): 259-271.
51. Ingebrigtsen TS, Marott JL, Vestbo J, et al. Gastro-esophageal reflux disease and exacerbations in chronic obstructive pulmonary disease. Respirology, 2015, 20(1): 101-107.
52. Mokhlesi B, Morris AL, Huang CF, et al. Increased prevalence of gastroesophageal reflux symptoms in patients with COPD. Chest, 2001, 119(4): 1043-1048.
53. Benson VS, Mullerova H, Vestbo J, et al. Associations between gastro-esophageal reflux, its management and exacerbations of chronic obstructive pulmonary disease. Respir Med, 2015, 109(9): 1147-1154.
54. 李慧靈, 阿不來提.艾則孜, 張成, 等胃食管反流病診治進展. 中華胃食管反流病電子雜志, 2015, 2(3): 175-177.

Previous Article
利用深度學習技術輔助肺結節的人工智能檢測
Next Article
茚達特羅在慢性阻塞性肺疾病中的臨床應用

Chinese Journal of Respiratory and Critical Care Medicine

慢性阻塞性肺疾病合并胃食管反流病的研究進展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content